Dr. Thomas J. Fogarty
Founder and Board Member
Dr. Thomas J. Fogarty is an internationally recognized cardiovascular surgeon, inventor, entrepreneur and investor. Throughout his career, he has been involved with a wide spectrum of innovations in business and technology. He has served as founder, Chairman or board member for more than 30 medical device companies, the majority of which were based on devices designed and developed by his company, Fogarty Engineering Inc.
Dr. Fogarty has published more than 180 scientific articles and textbook chapters in the fields of general and cardiovascular surgery, and is the author or co-author of more than 125 patents and patent applications. His patents include the industry standard Fogarty Balloon Embolectomy Catheter, which is now owned by Edwards Lifesciences LLC, and the widely used AneuRx AAA Stent Graft System, now owned by Medtronic Inc.
Dr. Fogarty is currently Adjunct Professor of Surgery at Stanford University. Previously, he held the positions of President of the Medical Staff at Stanford University Medical Center and Director of Cardiovascular Surgery at Sequoia Medical Center. He recently added the Fogarty Institute of Innovation at El Camino Hospital.
In addition to his work in the medical field, Dr. Fogarty is an accomplished investor. He founded and serves as Managing Director of Emergent Medical Partners LLP. He also was a founder and general partner at Three Arch Partners, and served as a general partner in five successive Three Arch venture funds.
Dr. Fogarty is the recipient of countless awards and honors, including the Jacobson Innovation Award presented by the American College of Surgeons and the 2000 Lemelson-MIT prize for Invention and Innovation. In December 2001, he was inducted into the Inventors Hall of Fame.
Dr. Fogarty received a Bachelor of Science degree from Xavier University and a medical degree from the University of Cincinnati. He completed his residency at the University of Oregon.
Roderick A. Young
Founder and Chairman
Roderick A. Young brings more than 20 years of executive experience in the medical device industry to CyberHeart. Mr. Young currently serves as a venture partner at Three Arch Partners, which he joined in May 2006.
Other management roles held by Mr. Young during his career include founder, President and CEO of Vivant Medical Inc., a Three Arch Partners medical device company focused on microwave ablation that was acquired by Tyco International Ltd. (now part of Covidien). He also was President and CEO of Targesome Inc., a biopharmaceutical company developing receptor-targeted agents to treat and diagnose cancer and other diseases, and CEO of Focus Surgery Inc., a pioneer in the development and commercialization of products using high intensity focused ultrasound.
During his career Mr. Young was Chairman, CEO of General Surgical Innovations Inc. (GSI), an emerging technology company funded by Three Arch Partners that developed the balloon dissection product line which was important to the growth of laparoscopic hernia repair. After successfully growing the organization, he led GSI through an initial public offering and acquisition by United States Surgical Corporation (now part of Covidien AG). He also was President of Toshiba America MRI Inc., President and COO of Diasonics, and Chief Financial Officer of Raychem.
Young received a Bachelor of Science degree in Industrial Engineering from Stanford University and a Masterís Degree in Business Administration from The Harvard Business School.